# Circulating Tumor DNA and Follow-up of BRCA1 Mutation Carriers (CirCa 01)

> **NCT02608346** · NA · COMPLETED · sponsor: **Institut Curie** · enrollment: 200 (actual)

## Conditions studied

- Women With BRCA1 Germline Deleterious Mutation

## Interventions

- **PROCEDURE:** Blood sampling

## Key facts

- **NCT ID:** NCT02608346
- **Lead sponsor:** Institut Curie
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2021-12-29
- **Final completion:** 2021-12-29
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2024-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02608346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02608346, "Circulating Tumor DNA and Follow-up of BRCA1 Mutation Carriers (CirCa 01)". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT02608346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*